Nebraska LB 779: Limit the amount an insured pays for prescription insulin drugs

Status: Indefinitely postponed (as of 2024-04-18)

State: Nebraska · Session: 108 · Bill: LB 779

Sponsors: Bostar, Conrad, Hunt

View Nebraska LB 779 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.